Bio-Rad Laboratories is a medical - devices company in the healthcare sector trading on NYSE, led by CEO Norman D. Schwartz, with a market cap of $7.5B.
Common questions about Bio-Rad Laboratories
Bio-Rad Laboratories is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $585.9M.
Bio-Rad Laboratories has approximately 8,030 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.